Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: Comparison of 30-, 60-, and 90-mg dosages
- 1 September 1993
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 95 (3), 297-304
- https://doi.org/10.1016/0002-9343(93)90282-t
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- RENAL PHOSPHATE THRESHOLD AND RESPONSE TO PAMIDRONATE IN HUMORAL HYPERCALCAEMIA OF MALIGNANCYThe Lancet, 1989
- Hungry bone syndrome: Clinical and biochemical predictors of its occurrence after parathyroid surgeryThe American Journal of Medicine, 1988
- REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENTThe Lancet, 1987
- Low dose intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) for the treatment of Paget's disease of bone.Annals Of The Rheumatic Diseases, 1986
- A single-day treatment of tumor-induced hypercalcemia by intravenous amino-hydroxypropylidene bisphosphonateJournal of Bone and Mineral Research, 1986
- Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factorsNature, 1986
- COMPARISON OF AMINOHYDROXYPROPYLIDENE DIPHOSPHONATE, MITHRAMYCIN, AND CORTICOSTEROIDSICALCITONIN IN TREATMENT OF CANCER-ASSOCIATED HYPERCALCAEMIAThe Lancet, 1985
- COMPARISON OF INTRAVENOUS (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE AND VOLUME REPLETION IN TUMOUR-INDUCED HYPERCALCAEMIAThe Lancet, 1983
- Differential Action of the Bisphosphonates (3-Amino-1-Hydroxypropylidene)-1,1-Bisphosphonate (APD) and Disodium Dichloromethylidene Bisphosphonate (Cl2MDP) on Rat Macrophage-mediated Bone Resorption In VitroJournal of Clinical Investigation, 1982
- FAILURE OF CORTICOSTEROID THERAPY TO CORRECT THE HYPERCALCÆMIA OF MALIGNANT DISEASEThe Lancet, 1970